
R-10015
CAS No. 2097938-51-5
R-10015( —— )
Catalog No. M22437 CAS No. 2097938-51-5
R-10015 is a potent and selective inhibitor of LIM domain kinase (LIMK) and binds to the ATP-binding pocket(IC50 of 38 nM for human LIMK1),and a broad-spectrum antiviral compound for HIV infection.R10015 as a lead compound that blocks LIMK activity by binding to the ATP-binding pocket.?
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 156 | In Stock |
![]() ![]() |
5MG | 259 | In Stock |
![]() ![]() |
10MG | 405 | In Stock |
![]() ![]() |
25MG | 668 | In Stock |
![]() ![]() |
50MG | 888 | In Stock |
![]() ![]() |
100MG | 1251 | In Stock |
![]() ![]() |
500MG | 2538 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameR-10015
-
NoteResearch use only, not for human use.
-
Brief DescriptionR-10015 is a potent and selective inhibitor of LIM domain kinase (LIMK) and binds to the ATP-binding pocket(IC50 of 38 nM for human LIMK1),and a broad-spectrum antiviral compound for HIV infection.R10015 as a lead compound that blocks LIMK activity by binding to the ATP-binding pocket.?
-
DescriptionR-10015 is a potent and selective inhibitor of LIM domain kinase (LIMK) and binds to the ATP-binding pocket(IC50 of 38 nM for human LIMK1),and a broad-spectrum antiviral compound for HIV infection.R10015 as a lead compound that blocks LIMK activity by binding to the ATP-binding pocket.?R10015 specifically blocks viral DNA synthesis, nuclear migration, and virion release.?In addition, R10015 inhibits multiple viruses, including Zaire ebolavirus (EBOV), Rift Valley fever virus (RVFV), Venezuelan equine encephalitis virus (VEEV), and herpes simplex virus 1 (HSV-1), suggesting that LIMK inhibitors could be developed as a new class of broad-spectrum antiviral drugs.
-
In VitroR-10015 (100 μM; 0-4 hours) inhibits cofilin phosphorylation directly through blocking LIM kinase in CEM-SS T cells.R-10015 inhibits HIV-1 DNA synthesis, nuclear migration, and virion release.R-10015 inhibits multiple viruses, including Zaire ebolavirus (EBOV), Rift Valley fever virus (RVFV), Venezuelan equine encephalitis virus (VEEV), and herpes simplex virus 1 (HSV-1) . Western Blot Analysis Cell Line:CEM-SS T cells Concentration:100 μM Incubation Time:0 hour,0.5 hour,1 hour,2 hours,4 hours Result:Inhibited cofilin phosphorylation directly through blocking LIM kinase in CEM-SS T cells.
-
In VivoR-10015 (10 mg/kg; i.p.) displays none indication of toxicity. The result suggests the possibility of short-term use of LIMK inhibitors to block viral infections. Animal Model:6-8 weeks female C3H/HeN mice Dosage:10 mg/kg Administration:Intraperitoneal injection Result:Displayed none indication of toxicity.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetLIM Kinase (LIMK)
-
Recptorhuman LIMK1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2097938-51-5
-
Formula Weight410.86
-
Molecular FormulaC20H19ClN6O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:62.5 mg/mL (152.12 mM; Need ultrasonic)
-
SMILESCOC(=O)c1ccc2[nH]c(nc2c1)C1CCN(CC1)c1ncnc2[nH]cc(Cl)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yi F, et al. Discovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1. J Virol. 2017 Jun 9;91(13). pii: e02418-16.
molnova catalog



related products
-
TH 257
TH 257 is a Potent and selective allosteric LIMK 1/2 inhibitor(LIMK1 and LIMK2 IC50 of 84 nM and 39 nM).
-
LIMK-IN-22j
LIMK-IN-22j is an effective and selective inhibitor of LIMK.
-
T.cruzi Inhibitor
T.cruzi Inhibitor is a Trypanosoma cruzi inhibitor.